Literature DB >> 7837212

Does insulin resistance participate in an impaired glucose tolerance in primary aldosteronism?

K Shimamoto1, M Shiiki, T Ise, Y Miyazaki, K Higashiura, M Fukuoka, A Hirata, A Masuda, M Nakagawa, O Iimura.   

Abstract

It has been reported that glucose intolerance is occasionally found in primary aldosteronism. In this study, we measured insulin sensitivity by the euglycaemic hyperinsulinaemic glucose clamp technique and ability to release insulin by 75 g oral glucose tolerance test (OGTT) in primary aldosteronism. Seven patients with primary aldosteronism (PA) (53.7 +/- 3.4 years; mean +/- SEM) and eight normotensive subjects (NS) (57.5 +/- 2.6 years) were employed in this study. The two-hour euglycemic hyperinsulinaemic glucose clamp technique was performed in seven PA before adrenalectomy, six PA after adrenalectomy and eight NS. The 75 g OGTT was also done in five PA before and after adrenalectomy and eight NS. The mean rate of glucose infusion to maintain euglycemia for the last 30 minutes of the clamp technique was used as an indicator of insulin sensitivity (M-value). The total blood glucose levels during 75 g OGTT (area under the curves) (sigma blood glucose) were significantly higher in PA than those in NS, and the total insulin levels during 75 g OGTT (area under the curves) (sigma IRI) were significantly lower in PA than those in NS. After adrenalectomy in PA, blood glucose levels were significantly decreased and IRI were significantly increased compared with the normal range. There was a significant positive correlation (P < 0.05, r = 0.71) between serum potassium levels and IRI in PA which were determined before and after adrenalectomy. In PA, M-values (240.7 +/- 14.6 mg/m2/min) were significantly higher than those in NS (199.0 +/- 12.3 mg/m2/min).(ABSTRACT TRUNCATED AT 250 WORDS)

Entities:  

Mesh:

Year:  1994        PMID: 7837212

Source DB:  PubMed          Journal:  J Hum Hypertens        ISSN: 0950-9240            Impact factor:   3.012


  12 in total

1.  Aldosterone decreases glucose-stimulated insulin secretion in vivo in mice and in murine islets.

Authors:  J M Luther; P Luo; M T Kreger; M Brissova; C Dai; T T Whitfield; H S Kim; D H Wasserman; A C Powers; N J Brown
Journal:  Diabetologia       Date:  2011-04-26       Impact factor: 10.122

2.  Marine natural product des-O-methyllasiodiplodin effectively lowers the blood glucose level in db/db mice via ameliorating inflammation.

Authors:  Rong Zhou; Zhong-Hui Lin; Cheng-Shi Jiang; Jing-Xu Gong; Li-Li Chen; Yue-Wei Guo; Xu Shen
Journal:  Acta Pharmacol Sin       Date:  2013-07-15       Impact factor: 6.150

Review 3.  Salt, aldosterone, and insulin resistance: impact on the cardiovascular system.

Authors:  Guido Lastra; Sonal Dhuper; Megan S Johnson; James R Sowers
Journal:  Nat Rev Cardiol       Date:  2010-08-10       Impact factor: 32.419

Review 4.  The effect of aldosterone on glucose metabolism.

Authors:  Dalila B Corry; Michael L Tuck
Journal:  Curr Hypertens Rep       Date:  2003-04       Impact factor: 5.369

5.  Spironolactone prevents dietary-induced metabolic syndrome by inhibiting PI3-K/Akt and p38MAPK signaling pathways.

Authors:  H D Long; Y E Lin; M J Liu; L Y Liang; Z H Zeng
Journal:  J Endocrinol Invest       Date:  2013-04-23       Impact factor: 4.256

Review 6.  The metabolic syndrome in primary aldosteronism.

Authors:  Francesco Fallo; Giovanni Federspil; Franco Veglio; Paolo Mulatero
Journal:  Curr Diab Rep       Date:  2008-02       Impact factor: 4.810

7.  In vivo tissue specific modulation of rat insulin receptor gene expression in an experimental model of mineralocorticoid excess.

Authors:  J Campión; V Lahera; V Cachofeiro; B Maestro; N Dávila; M C Carranza; C Calle
Journal:  Mol Cell Biochem       Date:  1998-08       Impact factor: 3.396

Review 8.  Effects of aldosterone on insulin sensitivity and secretion.

Authors:  James M Luther
Journal:  Steroids       Date:  2014-09-04       Impact factor: 2.668

9.  The prevalence of primary aldosteronism in diabetic patients.

Authors:  Dijana Jefic; Naushaba Mohiuddin; Rana Alsabbagh; Margaret Fadanelli; Susan Steigerwalt
Journal:  J Clin Hypertens (Greenwich)       Date:  2006-04       Impact factor: 3.738

10.  Primary Aldosteronism Decreases Insulin Secretion and Increases Insulin Clearance in Humans.

Authors:  Gail K Adler; Gillian R Murray; Adina F Turcu; Hui Nian; Chang Yu; Carmen C Solorzano; Robert Manning; Dungeng Peng; James M Luther
Journal:  Hypertension       Date:  2020-03-16       Impact factor: 10.190

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.